NASDAQ:MCOX (MCOX) (MCOX) Stock Price, News & Analysis → Urgent Nvidia Warning (From Altimetry) (Ad) Free MCOX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$3.90▼$3.9050-Day Range N/A52-Week Range$2.60▼$4.37VolumeN/AAverage Volume14,136 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (MCOX) alerts: Email Address Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. About (MCOX)Mecox Lane Limited is a holding company. The Company, through its subsidiaries, primarily offers health, beauty and lifestyle products under its own brands and of third-party brands through its call center, as well as other e-commerce channels in supplement, including its online store, WM18.com, third party e-commerce Websites, mobile platforms, WeChat and other social media networks in China. The Company's Maxicare brand offers health products, such as skincare beauty supplements, foundation nutrition, functional nutrition and weight management. The Company offers beauty products with a range of skin care and personal care products under La Celler and Skin Fairy brands. The Company offers lifestyle products, which include mattresses, air purifiers and home furnishing products under third party brands Ecolun, BeiAng and Homes-Up.Read More Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. MCOX Stock News HeadlinesJanuary 8, 2024 | msn.comHere's what restaurants are opening in the Triangle in 2024December 29, 2023 | msn.comYear Ender: Bollywood`s ride of blockbuster, controversies & social media stormsMay 4, 2024 | Behind the Markets (Ad)Investors Alert: The Next Big Thing in Weight LossUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year.December 29, 2023 | msn.comWhat’s happening around New Mexico December 29 – January 4December 29, 2023 | msn.comSpotty showers slowly taper off today before a chance for overnight snowfallFebruary 23, 2022 | morningstar.comClubessential Holdings Announces International Acquisition of InnovatiseJanuary 20, 2022 | apnews.comPrestoSports Announces Launch of Fundraising Solution PrestoRaiseSeptember 7, 2021 | msn.comVolunteers sought to mediate in local courtsMay 4, 2024 | Behind the Markets (Ad)Investors Alert: The Next Big Thing in Weight LossUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year.July 31, 2021 | finance.yahoo.comClubessential Launches Industry's First Tech Solutions Specifically for Lifestyle ClubsSee More Headlines Receive MCOX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (MCOX) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/07/2015Today5/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:MCOX CUSIPN/A CIK1501775 WebN/A Phone+86-21-64950500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report MCOX Stock Analysis - Frequently Asked Questions How were (MCOX)'s earnings last quarter? (MCOX) (NASDAQ:MCOX) announced its earnings results on Monday, December, 7th. The specialty retailer reported $0.08 earnings per share (EPS) for the quarter. The specialty retailer earned $15.09 million during the quarter. What other stocks do shareholders of (MCOX) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (MCOX) investors own include Alaska Communications Systems Group (ALSK), Amtech Systems (ASYS), AudioCodes (AUDC), Avid Bioservices (CDMO), China Techfaith Wireless Comm. Tech. (CNTF), Corcept Therapeutics (CORT), Cardiome Pharma (CRME), CTI BioPharma (CTIC), Energy Recovery (ERII) and EyePoint Pharmaceuticals (EYPT). This page (NASDAQ:MCOX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (MCOX) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
